BioElectronics Corporation BIEL

Company Overview

BioElectronics Corporation (OTC: BIEL) is a medical device company focused on non-invasive electroceutical technologies for pain management and recovery. The company develops and markets wearable pulsed shortwave therapy devices designed to reduce pain, inflammation, and edema without pharmaceuticals. BioElectronics operates within the medical technology, consumer healthcare, and electroceutical therapy industries, with products primarily targeting musculoskeletal pain, postoperative recovery, and chronic pain conditions.

The company’s primary revenue drivers have historically included sales and licensing of its flagship products, including ActiPatch, RecoveryRx, and related wearable therapy devices that use pulsed electromagnetic field (PEMF) or pulsed shortwave therapy technology. BioElectronics has positioned itself as a low-cost, over-the-counter alternative to certain pharmaceutical pain treatments, particularly amid broader healthcare interest in non-opioid pain management solutions. Founded in 2000, the company evolved from a small medical technology developer into a niche electroceutical device provider pursuing both direct-to-consumer and distribution-based commercialization strategies. Public disclosures indicate that commercialization efforts and regulatory access have been central to its business evolution.